Tong Ren Tang Technologies Renews Procurement, Sale Deals With Controlling Shareholder

MT Newswires Live

2025/09/30

Beijing Tong Ren Tang's (SHA:600085) subsidiary, Tong Ren Tang Technologies (HKG:1666), renewed two agreements with the company's controlling shareholder, China Beijing Tong Ren Tang (Group), for two more years, according to a Shanghai bourse filing on Tuesday.

The deal includes Tong Ren Tang Technologies' procurement of Chinese medicine raw materials and the sale of products between 2026 and 2028.

The procurement is estimated to cap at 45.5 million yuan between January and August and the sales at 57.7 million yuan in the same period, the Chinese pharmaceutical company said.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2571108394"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2571108394\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2571108394?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-30 12:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2571108394","market":"us","top_or_hot":-1,"title":"Tong Ren Tang Technologies Renews Procurement, Sale Deals With Controlling Shareholder","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/600085\">Beijing Tong Ren Tang</a>'s (SHA:600085) subsidiary, <a href=\"https://laohu8.com/S/TGRNF\">Tong Ren Tang Technologies</a> (HKG:1666), renewed two agreements with the company's controlling shareholder, China Beijing <a href=\"https://laohu8.com/S/01666\">Tong Ren Tang</a> (Group), for two more years, according to a Shanghai bourse filing on Tuesday.</p><p>The deal includes Tong Ren Tang Technologies' procurement of Chinese medicine raw materials and the sale of products between 2026 and 2028.</p><p>The procurement is estimated to cap at 45.5 million yuan between January and August and the sales at 57.7 million yuan in the same period, the Chinese pharmaceutical company said.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tong Ren Tang Technologies Renews Procurement, Sale Deals With Controlling Shareholder</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTong Ren Tang Technologies Renews Procurement, Sale Deals With Controlling Shareholder\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-09-30 12:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/600085\">Beijing Tong Ren Tang</a>'s (SHA:600085) subsidiary, <a href=\"https://laohu8.com/S/TGRNF\">Tong Ren Tang Technologies</a> (HKG:1666), renewed two agreements with the company's controlling shareholder, China Beijing <a href=\"https://laohu8.com/S/01666\">Tong Ren Tang</a> (Group), for two more years, according to a Shanghai bourse filing on Tuesday.</p><p>The deal includes Tong Ren Tang Technologies' procurement of Chinese medicine raw materials and the sale of products between 2026 and 2028.</p><p>The procurement is estimated to cap at 45.5 million yuan between January and August and the sales at 57.7 million yuan in the same period, the Chinese pharmaceutical company said.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1191","symbol_name":"制药","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2571108394","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2571108394","pubTimestamp":1759205114,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Beijing Tong Ren Tang's  subsidiary, Tong Ren Tang Technologies , renewed two agreements with the company's controlling shareholder, China Beijing Tong Ren Tang , for two more years, according to a Shanghai bourse filing on Tuesday.The deal includes Tong Ren Tang Technologies' procurement of Chinese medicine raw materials and the sale of products between 2026 and 2028.The procurement is estimated to cap at 45.5 million yuan between January and August and the sales at 57.7 million yuan in the same period, the Chinese pharmaceutical company said.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"600085":"同仁堂","BK1191":"制药","BK1515":"抗疫概念","01666":"同仁堂科技","BK0188":"融资融券","BK0012":"证金概念","TGRNF":"Tong Ren Tang Technologies","BK0196":"行业龙头","LU1688375341.USD":"贝莱德中国灵活股票基金","BK1606":"中医药概念","BK1583":"高瓴概念","BK0239":"医药制造","BK4007":"制药","BK0097":"医药电商","BK0113":"养老产业","BK0028":"国家队","BK0086":"举牌","BK0183":"MSCI概念"},"translate_title":"同仁堂科技与控股股东续签采购、销售协议","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600085":0.9,"TGRNF":1.5,"01666":1},"content_text":"Beijing Tong Ren Tang's (SHA:600085) subsidiary, Tong Ren Tang Technologies (HKG:1666), renewed two agreements with the company's controlling shareholder, China Beijing Tong Ren Tang (Group), for two more years, according to a Shanghai bourse filing on Tuesday.The deal includes Tong Ren Tang Technologies' procurement of Chinese medicine raw materials and the sale of products between 2026 and 2028.The procurement is estimated to cap at 45.5 million yuan between January and August and the sales at 57.7 million yuan in the same period, the Chinese pharmaceutical company said.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}